Blueprint Genetics Revenue and Competitors
Estimated Revenue & Valuation
- Blueprint Genetics's estimated annual revenue is currently $38.5M per year.
- Blueprint Genetics's estimated revenue per employee is $150,500
- Blueprint Genetics's total funding is $26.3M.
- Blueprint Genetics has 256 Employees.
- Blueprint Genetics grew their employee count by -18% last year.
What Is Blueprint Genetics?
Blueprint Genetics is a genetic diagnostics company based in Helsinki, San Francisco and Dubai. We provide world-class genetic diagnostics and clinical interpretation for hereditary diseases. We are passionate about changing peoples lives through development of groundbreaking solutions that take genetic diagnostics from niche to mainstream. Our global team of innovative and ambitious people are working at the forefront of genetic knowledge, AI and other areas of life science. Our team consists of more than 20 nationalities working as geneticists, data analysts, laboratory technicians, client service specialists, genetic services consultants, software developers and marketing specialists. Today, we work with customers in over 40 countries and push to make genetic knowledge easier to access for the medical community. Our comprehensive and cost effective genetic tests support healthcare professionals around the world in providing the best care for patients and families with rare inherited diseases. We provide a very comprehensive test portfolio. We cover more than 2,500 genes with our NGS platform, provide more than 220 targeted panels and world-class Whole Exome Sequencing. We take pride in sharing data and being transparent about our sequencing quality and pricing.keywords:N/A
Number of Employees
Employee Growth %
Blueprint Genetics News
Scientists say they have finally assembled the full genetic blueprint for human life, adding the missing pieces to a puzzle nearly completed...
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announce today that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-ba ...
“The great challenge with genetic testing is generating quality, actionable and broadly accessible insights from vast quantities of sequenced genetic data,” Quest CEO Steve Rusckowski said in a statement. “Blueprint Genetics has developed a proven model for delivering highly specialized genetic ...
Global Genetic Testing Market Research Report 2019: Industry Size, ... F. Hoffmann-La Roche Ltd (Switzerland), Blueprint Genetics (Finland), ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|